Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Irem Durmaz Sahin"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Cancer is one of the leading causes of death worldwide, accounting for nearly 10 million deaths in 2020. Current treatment methods include hormone therapy, γ-radiation, immunotherapy, and chemotherapy. Although chemotherapy is the most effe
Externí odkaz:
https://doaj.org/article/c141393a5bf04af99002d9e25a04c70d
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 22:1340-1347
Background: Although transplantation, surgical resection, and tumor ablation are treatment options available following early diagnosis of HCC, poor prognosis and high recurrence rates restrict the efficacy of these approaches. Hence, small molecules
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fec5b38a285c86419cd9af880ad148b
https://doi.org/10.2174/1871520621666210623093550
https://doi.org/10.2174/1871520621666210623093550
Autor:
Daniele Passarella, Çiğdem Tepe Karaca, Irem Durmaz Sahin, Michael S. Christodoulou, Rengul Cetin-Atalay, Ece Akhan Güzelcan, Altay Koyas
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Hepatocellular carcinoma (HCC) ranks as the fifth most common and the second deadliest cancer worldwide. HCC is extremely resistant to the conventional chemotherapeutics. Hence, it is vital to develop new treatment options. Chalcones were previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c32efad6edd4beb325765f60ef64cd17
http://link.springer.com/article/10.1038/s41598-020-68775-9
http://link.springer.com/article/10.1038/s41598-020-68775-9
Autor:
Jenny-Maria Jönsson, Maria Bååth, Ida Björnheden, Irem Durmaz Sahin, Anna Måsbäck, Ingrid Hedenfalk
Publikováno v:
Cancers
Volume 13
Issue 2
Cancers, Vol 13, Iss 254, p 254 (2021)
Volume 13
Issue 2
Cancers, Vol 13, Iss 254, p 254 (2021)
Serous endometrial cancer (SEC) resembles high-grade serous ovarian cancer (HGSOC) genetically and clinically, with recurrent copy number alterations, TP53 mutations and a poor prognosis. Thus, SEC patients may benefit from targeted treatments used i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fb05cbcea207a1a5f0f05cfcae696cad
http://europepmc.org/articles/PMC7827019
http://europepmc.org/articles/PMC7827019
Autor:
Elif Merve Aydin, İdil Su Canıtez, Eleonora Colombo, Salvatore Princiotto, Daniele Passarella, Sabrina Dallavalle, Michael S. Christodoulou, Irem Durmaz Şahin
Publikováno v:
Molecules, Vol 28, Iss 23, p 7777 (2023)
Ovarian cancer ranks as the eighth most prevalent form of cancer in women across the globe and stands as the third most frequent gynecological cancer, following cervical and endometrial cancers. Given its resistance to standard chemotherapy and high
Externí odkaz:
https://doaj.org/article/0af8e3e1500c4e7b817f0031040fe118